- 1
- 0
- 约1.82万字
- 约 4页
- 2018-12-13 发布于天津
- 举报
视网膜光凝联合玻璃体内注射雷珠单抗治疗缺血型视网膜分支.PDF
眼科新进展 2018年4月 第38卷 第4期
·348· http://www.ykxjz.com RecAdvOphthalmol Vol.38No.4April2018
欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁氉
欁
氉
引文格式:江慧娟,庞东渤.视网膜光凝联合玻璃体内注射雷珠单抗治疗缺血型视网膜分支静脉阻塞(BRVO)致黄
欁
欁
欁 斑水肿的疗效[J].眼科新进展,2018,38(4):348351.doi:10.13389/j.cnki.rao.2018.0081 【应用研究】
氉欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁欁氉
视网膜光凝联合玻璃体内注射雷珠单抗治疗缺血型视网膜分支
静脉阻塞(BRVO)致黄斑水肿的疗效△
江慧娟 庞东渤
欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞欞
欁欁欁欁欁欁欁欁欁欁欁氉
欁
氉 Efficacyofintravitrealranibizumabcombinedwithla
欁 作者简介:江慧娟,女,1990年7月 欁
欁 出生,河北邢台人,在读硕士研究 欁 serphotocoagulationforthetreatmentofmacularede
欁 生。主要研究方向为眼底疾病。联 欁 mainducedbyischemicbranchretinalveinocclusion
欁 系电话:15734201863;Email:yk欁
欁 drjiang@ 163.com;ORCID:0000欁 JIANGHuiJuan,PANGDongBo
欁000202797266 【Abstract】 Objective Toobservethetherapeuticefficacyofintravitrealranibi
欁 AboutJIANG HuiJuan:Female,欁欁 zumabcombinedwithlaserphotocoagulationforthetreatmentofmacularedemaasso
欁 ciatedwithischemicbranchretinalveinocclusion(BRVO).Methods Together60
欁 born in July,1990.Postgraduate欁
欁
student.Tel:15734201863;Email: patients(60eyes)withBRVOinAnshanCityCentralHospitalwereincludedanddivid
欁
欁
ykdrjiang@163.com;ORCID:0000 edintothreegroups,20patientswithintravitrealranibizumabtreatmentasAgroup,20
欁
欁
欁000202797266 patientswithretinallaserphotocoagulationtreatmentasBgroup,andanother20pa
欁
原创力文档

文档评论(0)